Monte Rosa Therapeutics, Inc. logo

Monte Rosa Therapeutics, Inc.

GLUENASDAQ

Monte Rosa Therapeutics, Inc. is a biotechnology company in the healthcare sector on NASDAQ, led by Jennifer Champoux, with a market cap of $1.1B. As of Q3 2025, 97% of shares are held by 126 institutional investors, with NEA Management Company, LLC as the largest holder at 12.46%.

Chief Executive OfficerJennifer Champoux
Market Cap$1.1B
Biotechnology
Healthcare
Employees109.0
Country
United States of America

Overview

Overview of institutional ownership in GLUE as of Q3 2025 with a market cap of $457.6M

All Institutions

Institutions
126
Value Held
$444.8M
Shares Held
60.0M
Avg Position
$3.5M
Median Position
$257.1K

Hedge Funds

Hedge Funds
22
Value Held
$95.1M
Shares Held
12.8M
Avg Position
$4.3M
Median Position
$913.1K

Ownership Breakdown

Institutional (non-HF): 76.42%Institutional (non-HF)Hedge Funds: 20.77%Hedge FundsRetail & Other: 2.80%
Institutional (non-HF)
76.42%
$349.7M
Hedge Funds
20.77%
$95.1M
Retail & Other
2.8%
$12.8M

Based on market cap of $457.6M as of Q3 2025. Institutional (non-HF) excludes hedge funds to avoid double counting.

Biggest Investors

Institutions with the largest positions in GLUE as of Q3 2025

InstitutionPosition Value
$57.0M
3.13% of portfolio
B
BVF INC/IL
Institution
$41.9M
1.70% of portfolio
$41.9M
19.72% of portfolio
B
BAKER BROS. ADVISORS LP
Hedge FundSector
$36.4M
0.34% of portfolio
$34.4M
0.00% of portfolio
B
BlackRock, Inc.
Institution
$28.3M
0.00% of portfolio
SUVRETTA CAPITAL MANAGEMENT, LLC logo
SUVRETTA CAPITAL MANAGEMENT, LLC
Hedge FundLong/Short
$24.9M
0.75% of portfolio
$22.1M
0.00% of portfolio
FMR LLC logo
FMR LLC
Institution
$20.8M
0.00% of portfolio
$10.9M
2.39% of portfolio

Net Capital Flow

Institutional buying and selling activity for GLUE in Q3 2025

Net Flow
$28.7M
Buyers
36
Sellers
55
Total Bought
+$16.9M
Total Sold
$45.6M
Avg Position
$3.6M

Biggest Buyers

InstitutionNet Bought
FMR LLC logo
FMR LLC
Institution
+$3.9M
+524.2K shares
+$3.4M
+456.8K shares
MILLENNIUM MANAGEMENT LLC logo
MILLENNIUM MANAGEMENT LLC
Hedge FundMulti-Strategy
+$2.8M
+380.3K shares
+$1.4M
+190.3K shares
+$1.4M
+184.0K shares
+$1.2M
+157.4K shares
+$648.0K
+87.5K shares
MORGAN STANLEY logo
MORGAN STANLEY
RIA/Wealth
+$553.9K
+74.7K shares
+$245.4K
+33.1K shares
Invesco Ltd. logo
Invesco Ltd.
ETF Provider
+$240.9K
+32.5K shares

Biggest Sellers

InstitutionNet Sold
$16.8M
3.7M shares
$12.5M
1.7M shares
AQR CAPITAL MANAGEMENT LLC logo
AQR CAPITAL MANAGEMENT LLC
Hedge FundMulti-Strategy
$4.2M
566.7K shares
$1.8M
247.1K shares
$1.6M
219.4K shares
$1.1M
151.6K shares
GSA CAPITAL PARTNERS LLP logo
GSA CAPITAL PARTNERS LLP
Hedge FundQuant
$1.1M
150.4K shares
S
Squarepoint Ops LLC
Hedge FundQuant
$618.2K
83.4K shares
TWO SIGMA INVESTMENTS LLC logo
TWO SIGMA INVESTMENTS LLC
Hedge FundMulti-Strategy
$581.4K
78.5K shares
ExodusPoint Capital Management, LP logo
ExodusPoint Capital Management, LP
Hedge FundMulti-Strategy
$492.6K
109.2K shares

Entry and Exit Activity

Institutions that initiated new positions or completely exited GLUE in Q3 2025

New Positions
16
New Value
$6.7M
Exited Positions
14
Exited Value
$18.2M

New Positions

InstitutionPosition Value
A
ADAR1 Capital Management, LLC
Hedge FundLong/Short
$1.6M
215.8K shares
$1.5M
200.0K shares
J
$1.1M
148.6K shares
R
Rangeley Capital, LLC
Hedge FundEvent Driven
$837.3K
113.0K shares
$648.0K
87.5K shares
C
Campbell & CO Investment Adviser LLC
Hedge FundQuant Macro
$378.9K
51.1K shares
$209.7K
28.3K shares
Scientech Research LLC logo
Scientech Research LLC
Hedge FundMarket Neutral
$120.4K
16.3K shares
$88.6K
12.0K shares
Engineers Gate Manager LP logo
Engineers Gate Manager LP
Hedge FundQuant
$80.6K
10.9K shares

Exited Positions

InstitutionPrevious Position
$16.8M
3.7M shares
ExodusPoint Capital Management, LP logo
ExodusPoint Capital Management, LP
Hedge FundMulti-Strategy
$492.6K
109.2K shares
$271.1K
60.1K shares
$159.7K
35.4K shares
$135.3K
30.0K shares
$108.7K
24.1K shares
S
$98.6K
21.9K shares
$58.4K
13.0K shares
$49.0K
10.9K shares
$47.6K
10.6K shares

Options Activity

Institutions with the largest Call and Put options positions in GLUE as of Q3 2025

Call Positions
3
Call Value
$1.2M
Put Positions
3
Put Value
$2.0M

Call Positions

InstitutionPosition Value
$895.9K
1.2K contracts
$206.0K
278.0 contracts
CITADEL ADVISORS LLC logo
CITADEL ADVISORS LLC
Hedge FundMulti-Strategy
$74.8K
101.0 contracts

Put Positions

InstitutionPosition Value
$1.3M
1.7K contracts
$510.5K
689.0 contracts
CITADEL ADVISORS LLC logo
CITADEL ADVISORS LLC
Hedge FundMulti-Strategy
$211.2K
285.0 contracts

Most Committed Institutions

Institutions with GLUE as the highest % of their portfolio as of Q3 2025

InstitutionPortfolio Weight
19.72%
$41.9M
3.13%
$57.0M
2.39%
$10.9M
B
BVF INC/IL
Institution
1.70%
$41.9M
R
Rangeley Capital, LLC
Hedge FundEvent Driven
0.79%
$837.3K
SUVRETTA CAPITAL MANAGEMENT, LLC logo
SUVRETTA CAPITAL MANAGEMENT, LLC
Hedge FundLong/Short
0.75%
$24.9M
SILVERARC CAPITAL MANAGEMENT, LLC logo
SILVERARC CAPITAL MANAGEMENT, LLC
Hedge FundLong/Short
0.75%
$5.1M
P
Parkwood LLC
Institution
0.53%
$5.2M
Alphabet Inc. logo
Alphabet Inc.
Institution
0.45%
$10.8M
B
BAKER BROS. ADVISORS LP
Hedge FundSector
0.34%
$36.4M

Hedge Fund Spotlight

Discover hedge funds investing in GLUE

B
BAKER BROS. ADVISORS LP
Hedge FundSector
Portfolio ManagerScott Lawrence Lessing
Portfolio Value
$10.8B
Positions
88
Last Reported
Q3 2025
AddressNew York, NY
Sector Allocation
Healthcare: 95.20%Healthcare
Monte Rosa Therapeutics, Inc. logo

Position in Monte Rosa Therapeutics, Inc.

Market Value
$36.4M
Shares Held
4.9M
Portfolio Weight
0.34%
Owned Since
2023-Q1
Top HoldingSectorMarket ValueWeight
1
Incyte logo
Incyte
INCY
Biotechnology
Healthcare
$2.6B24.14%
Biotechnology
Healthcare
$982.3M9.10%
3
Insmed logo
Insmed
INSM
Biotechnology
Healthcare
$965.4M8.94%

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.